Global Leukemia Therapeutics Market Study, Insights, Opinions and Forecast to 2021
Extensive market analysis of Global Leukemia Therapeutics Market that provides a detailed information on growth opportunities, recent trends and challenges
Extensive market analysis of Global Leukemia Therapeutics Market that provides a detailed information on growth opportunities, recent trends and challenges
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Global</strong> <strong>Leukemia</strong> <strong>Therapeutics</strong> <strong>Market</strong><br />
According <strong>to</strong> the report "<strong>Leukemia</strong> <strong>Therapeutics</strong>", published by <strong>Market</strong> Data <strong>Forecast</strong>, the<br />
global market is projected <strong>to</strong> reach USD 8.82 Billion by <strong>2021</strong>, at a CAGR of 9.5% from 2016<br />
<strong>to</strong> <strong>2021</strong>.<br />
<strong>Leukemia</strong> is the type of blood cancer <strong>and</strong> the ninth most common one in males. It accounts<br />
for almost 0.0148% of all the men <strong>and</strong> 0.009% of all the women worldwide. It is a type of<br />
blood cancer resulting in the abnormal production of blood cells, generally leukocytes.<br />
<strong>Leukemia</strong> cases are more common in adults <strong>and</strong> are observed <strong>to</strong> progress with aging.<br />
Rising prevalence of leukemia, funding <strong>to</strong> increase disease awareness, <strong>and</strong> increasing<br />
consumer awareness regarding leukemia treatments <strong>and</strong> drugs are the main fac<strong>to</strong>rs that are<br />
driving the market growth. Government support <strong>and</strong> enhanced healthcare infrastructure<br />
are providing opportunities for the manufacturers <strong>to</strong> penetrate in<strong>to</strong> this market.<br />
<strong>Global</strong> <strong>Market</strong> for <strong>Leukemia</strong> <strong>Therapeutics</strong> is segmented based on Type <strong>and</strong> Product in<strong>to</strong><br />
further sub-segments as follows:<br />
1. By disease condition<br />
Chronic lymphatic leukemia<br />
Acute lymphatic leukemia<br />
Chronic myeloid leukemia<br />
Acute myeloid leukemia<br />
2. By diagnosis<br />
CT scan<br />
Biopsy<br />
MRI<br />
3. By treatments<br />
Chemotherapy<br />
Radiation therapy<br />
Immunotherapy<br />
Surgery<br />
Targeted therapy<br />
Bone marrow transplant<br />
Stem cell therapy<br />
4. By drugs<br />
Gleevec<br />
Sapacitabine<br />
GA101<br />
Vasaroxine<br />
Tosedosat<br />
Geographically, the market for <strong>Leukemia</strong> <strong>Therapeutics</strong> market is segmented as below:<br />
<br />
<br />
North America<br />
Europe<br />
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com
Change language